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Abstract. Positron Annihilation Lifetime Spectroscopy (PALS) allows examining structure of materials in nano and sub-nanometer
scale. This technique is based on the lifetime and intensity of ortho-positronium atoms in free volumes of given structures. It is
mostly used for studies in material sciences, but it can also be used for in vivo imaging of the cell morphology as proposed in
[1], [2]. Cancer cells are characterized by an altered macro structure in comparison to normal cells, thus the main objective of
these studies is to compare if these differences can be detected on sub-nanometer level and therefore allows to distinguish between
normal and cancer cells with application of PALS technique.
This perspective will allow for simultaneous determination of early and advanced stages of carcinogenesis, by observing
changes in biomechanical parameters between normal and tumour cells, and standard PET examination. Such simultaneous PET
imaging and PALS investigations can be performed with the Jagiellonian Positron Emission Tomograph (J-PET) which is a multi-
purpose detector used for investigations with positronium atoms in life-sciences as well as for development of medical diagnostics.
INTRODUCTION
Proposed investigation mainly concerns the studies of the cellular organization and structure at nano and sub-
nanometer level and its relation to the cell morphology and signalling. Correlations between cellular processes such as
proliferative activity and proapoptotic sensitivity (activity) and Positron Annihilation Lifetime Spectroscopy (PALS)
parameters can be determined. Different living normal and cancer cells and tissues will be investigated in order to
connect PALS parameters to carcinogenesis and metastatic processes. Cancer cells differ from normal ones by their
structure and organelles functionality. These cells are irregular in shape, have a reduced amount of cytoplasm, a bigger
and often multiplied nuclei. Organelles such as the Golgi apparatus, mitochondria or endoplasmic reticulum become
disorganized or have impaired function. Even though main factors responsible for DNA mutations leading to cancer
have been broadly studied over the last few years, there is slight evidence about the molecular structure of the cell,
their ultrastructure and the difference between normal cells and cancer cells in proliferation, protein and lipid synthesis
and intracellular transport.
In our studies we test the hypothesis [1], [2] that cancer cells differ in their sub-nanostructure, molecular inter-
actions or activity, which are specific for cancer. These changed molecular interactions may influence their molecular
properties that can be detected as the changed PALS signal. Such detailed research in this area have not been con-
ducted so far, mostly due to the limitations of experimental technique currently used in cell biology. Recently, the
optical super resolution microscopy techniques like Stimulated Emission Depletion (STED) [3] or Photoactivated Lo-
calization Microscopy (PALM) [4] were developed to overcome the barrier of optical resolution and allow to study
living biological objects with resolution between 1−100 nm. However, those techniques cannot report on the dynamic
behavior of the cellular matter and mostly they require usage of fluorescent labels. When methods like Scanning Elec-
tron Microscopy give information of biological specimens at the nano and sub-nanometer scale, but for such accuracy
it acquires fixed or dehydrated samples, thus all these studies can be performed only in vitro. Observed changes in
biomechanical parameters between normal and tumor cells can be correlated with parameters obtained from PALS
technique. Combining this technique with J-PET detector [5], [6], [7], [8], [9], [10] would make possible in vivo
studies of human cells and tissues in nanometer scale and could be used as additional diagnostic parameter [1], [2].
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DIFFERENCE BETWEEN STRUCTURE AND METABOLISM IN NORMAL AND
CANCER CELLS
Cells and tissues are inherently very complex in their structure. Main research in cell biology and biophysics aims
to explain and understand how living processes, which occur on the cellular level are regulated in different spatial
and temporal domains. The main challenge in these studies is that the living objects are built of different cellular
and molecular structures and chemical compounds, which function depend on many environmental and intracellular
factors. Many studies are carried out in the macro and micro spatial distribution but there are only few of them that
investigate the regulation of cellular processes in the context of changes at a nano- and sub-nanometer scale of the
living objects. The goal of this research is to study normal and cancer cells, as well as compounds building their
structure, and cells interactions with extracellular matrix into nano scale using the PALS technique, this will allow for
non-optical investigation of the biological structures.
Studies conducted by the J-PET collaboration aim at bringing the new insight into the carcinogenesis; not only on
the genetic and cell physiology levels (mutagenesis, apoptosis, proliferation etc.), but also on the molecular structure
in the nano scale, including temporal and spatial domains in the correlation with the free volumes between molecules.
Many superimposed factors are responsible for carcinogenesis. Cancer cells show high variations in their genetic
and biochemical parameters. Current research demonstrates that mechanical and structural properties of cytoskeleton,
cellular environment and even cell nucleus play a major role in carcinogenesis and metastatic processes. Changes
in the cellular membranes or cytoskeleton at the macro scale strongly indicate the changes at the micro scale of the
membrane, and this could be caused at even smaller level in nano or sub-nano scale [11]. Cancer cells can be divided
into two types: benign and malignant. Benign cells have a similarity to their stem cell and are well differentiated,
and therefore tumors are progressing slowly as an encysted change. These tumors do not form metastases. Malignant
tumors have less differentiated cells and the ability to infiltrate surrounding tissues and cause metastasis [12].
POSITRON ANNIHILATION LIFETIME SPECTROSCOPY
Positronium is a hydrogen like atom and, at the same time anti-atom. It is build out of electron and its anti-particle
positron. Its bounding energy is equal to 6.8 eV and its diameter amounts to about 0.2 nm, and hence it is sufficiently
small to be trapped in the volumes of lower electron density, so called free volumes between molecules in various liv-
ing and non-living matter. The smaller are the free voids between molecules and atoms the shorter the o-Ps lifetime.
This is due to the pick-off processes in which positron from the positronium may annihilate with one of the surround-
ings electrons. Shortening its lifetime, when embedded in the matter, can be used for studies of nanomorphology of
cells in living organisms [1], [2]. Positronium may be formed in tryplet state as para-positronium (p-Ps), with the
average lifetime in a vacuum of τp−Ps = 0.125 ns, or in singlet state as ortho-positronium (o-Ps) with the average
lifetime in a vacuum of τo−Ps = 142 ns.
Based on theory by Tao [13] and Eldrup [14] correlation between the lifetime of the ortho-positronium atoms
with the free voids size can be determined. These changes of the o-Ps lifetime and intensity of its production are
crucial for the biological research. What is important, positronium can also be created in liquids such as water what
allows to study living cells. The average lifetime of o-Ps in pure liquid water amounts to about 1.8 ns [15].
Current PALS application in biology
There are few works demonstrating the application of PALS technique to study biological structures. Jean and his
group [16] described some applications of positron annihilation techniques in biological systems. They focused on
studies of healthy and abnormal skin samples and reported that o-Ps lifetime and therefore free volumes are correlated
with the level of skin damage. Both intensity and lifetime of o-Ps were found to be significantly lower in samples with
basal cell carcinoma (BCC) and squamous cell carcinoma (SCC) than in normal skin samples. These studies were
performed on fixed samples as well as in ambient conditions [17],[18].
Another example of advanced PALS application in studies of cell culture is the paper by Axpe et al. [19], where
they employed well defined colorectal cancer cell lines grown in the 3D matrix. Axpe shown how addition of a growth
factor TGF − β induces changes at the atomic scale in the size of the free volume voids, due to the biological effects.
This studies were carried out in 4 C deg. and showed the possibility of using PALS for live cells research.
Some recent PALS studies performed by the J-PET collaboration with simple model micro-organisms unicellular
yeasts Saccharomyces cerevisiae [20], shows the possibility to observe dynamics of the water sorption by lyophilised
(freeze - dry yeast). Lifetime of ortho-positronium was found to change from 2.4 to 2.9 ns (longer-lived compo-
nent) for lyophilized and aqueous yeasts, respectively. Also some temporal changes of the o-Ps lifetime indicating
reorganization of yeast in the molecular scale in the presence of liquid water was observed.
Recently, significant differences in PALS parameters between normal and tumor tissues were also observed by
the J-PET group in samples of uterine leiomyomatis and normal myometrium tissues taken from women-patients after
surgery [21], [22]. In case of all samples from six patients it was found that mean o-Ps lifetime are of about 2 ns, while
for normal tissues this value is of about 50 ps lower. The above discussed results indicate that in all investigations
performed to date there is a difference in PALS parameters determined for healthy and cancerous tissues.
o-Ps lifetime as a new diagnostic parameter with J-PET
All studies described in previous section brought important information, showing that PALS technique can be applied
in studies of biological structures and human cells and tissues, thus has potential as application in cancer diagnos-
tic. Nevertheless, this studies with PAL spectrometer can only be conducted in vitro. With J-PET scanner [6], [7],
[23], [24], [25], [26], [27] which is a multi-purpose detector used for investigations with positronium atoms in life-
sciences as well as for development of medical diagnostics, such simultaneous PET imaging and PALS measurement
is possible, therefore J-PET is capable of imaging properties of positronium produced inside the human body [1], [2].
Currently detector is calibrated and first PALS studies of porous material (XAD4 polymer) were performed and
results are already in press [28]. This allows for use of the J-PET scanner for PALS measurement with human tissue.
First such studies were performed with fixed in formaldehyde Cardiac Myxoma [29]- benign heart tumor- sample. The
data are collected in the triggerless mode by the dedicated electronics [30] and the digital data acquisition system [24],
[31]. The analysis is preformed with the root-based framework [32]. In Fig.1 (right) obtained lifetime spectra with
time resolution of about 270 ps (sigma) was acquired. o-Ps lifetime and intensity was calculated by PALS avalanche
program [27] with results τo−Ps = 2.03(01) and Io−Ps = 25.7(1)% respectively. With this measurement we have proven
that J-PET can be used not only for PET imaging but also for PALS studies of human tissue.
FIGURE 1. (left) Photo of J-PET scanner with Cardiac Myxoma inside the holder during measurement. (right) Positronium
lifetime spectrum obtained with the J-PET for cardiac myxoma.
SUMMARY
Presented idea of applying PALS for biological studies is quite a new concept, so far few studies, including ones con-
ducted by the J-PET collaboration [20], [21],[22] proven that this technique can be used successfully to differentiate
between normal and cancer tissues, therefore can be used in medical diagnostic. Differences between structure and
metabolisms of normal and cancer cells, were discussed in this article, but till now there is no explanation what is
the reason behind differences observed in PALS. Such information will be crucial for biomedical application. Planned
measurements with well defined cell lines possible with use of J-PET scanner will allow to study influence of different
factors, like free radicals, reactive oxygen species and glucose metabolism, and thus can lead to some possible model
of positronium trapping in living matter and perhaps some new information on carcinogenesis.
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